Biomarker driven drug development for fibroinflammatory diseases
Fibroinflammatory diseases, characterized by chronic inflammation and dysregulated tissue remodeling, represent a major unmet medical need across multiple organ systems. Advances in translational medicine have driven a paradigm shift toward biomarker-driven drug development. This presentation will highlight strategies for integrating biomarkers throughout the discovery and development continuum—fr...
2025-11-23